2008
DOI: 10.1517/14656566.9.6.1039
|View full text |Cite
|
Sign up to set email alerts
|

Tibolone: the way to beat many a postmenopausal ailments

Abstract: Clinical trials prove that tibolone is effective in the treatment of the menopausal symptoms and for the postponement and calming of symptoms accompanying age-related diseases. The findings of basic researchers that tibolone affects the metabolism of every cell, including malignant cells, opened a door to a whole new domain of research that has a promising future.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2009
2009
2018
2018

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 75 publications
0
2
0
Order By: Relevance
“…Tibolone is used for the treatment of menopausal symptoms and for the postponement and calming of symptoms accompanying agerelated diseases (72). A case of a patient under tibolone therapy for 2 years who developed a mixed-type liver injury with prolonged cholestasis and features of the vanishing bile duct syndrome following a 10-week treatment with SJW has been reported (73).…”
Section: Hormonal Therapymentioning
confidence: 99%
“…Tibolone is used for the treatment of menopausal symptoms and for the postponement and calming of symptoms accompanying agerelated diseases (72). A case of a patient under tibolone therapy for 2 years who developed a mixed-type liver injury with prolonged cholestasis and features of the vanishing bile duct syndrome following a 10-week treatment with SJW has been reported (73).…”
Section: Hormonal Therapymentioning
confidence: 99%
“…Tibolone is a synthetic compound with mixed oestrogenic, progestogenic and androgenic activities, representing an alternative to conventional HRT (Lazovic et al, 2008). It represents an efficient option for vasomotor symptoms alleviation or prevention of BMD loss in menopausal women (Gallagher et al, 2001;Swanson et al, 2006).…”
Section: Other Therapeutic Optionsmentioning
confidence: 99%